These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 6383194)

  • 1. Fibrinogen and fibrin.
    Doolittle RF
    Annu Rev Biochem; 1984; 53():195-229. PubMed ID: 6383194
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrin: structure and interactions.
    Hermans J; McDonagh J
    Semin Thromb Hemost; 1982 Jan; 8(1):11-24. PubMed ID: 7036348
    [No Abstract]   [Full Text] [Related]  

  • 3. Human fibrinogen.
    Shafer JA; Higgins DL
    Crit Rev Clin Lab Sci; 1988; 26(1):1-41. PubMed ID: 3286116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
    Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen and Fibrin in Hemostasis and Thrombosis.
    Kattula S; Byrnes JR; Wolberg AS
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):e13-e21. PubMed ID: 28228446
    [No Abstract]   [Full Text] [Related]  

  • 6. Structural aspects of the fibrinogen to fibrin conversion.
    Doolittle RF
    Adv Protein Chem; 1973; 27():1-109. PubMed ID: 4589664
    [No Abstract]   [Full Text] [Related]  

  • 7. Degradation products of fibrinogen and fibrin in bacteremia due to gram-negative rods.
    Satterwhite TK; Hawiger J; Burklow SL; Koenig MG
    J Infect Dis; 1973 Apr; 127(4):437-41. PubMed ID: 4694546
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinogen anomalies and disease. A clinical update.
    Galanakis DK
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1171-87. PubMed ID: 1400080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinogen and fibrin formation and its role in fibrinolysis.
    Blombäck B
    Biotechnology; 1991; 19():225-79. PubMed ID: 1723911
    [No Abstract]   [Full Text] [Related]  

  • 11. Lateral packing of protofibrils in fibrin fibers and fibrinogen polymers.
    Voter WA; Lucaveche C; Blaurock AE; Erickson HP
    Biopolymers; 1986 Dec; 25(12):2359-73. PubMed ID: 3801588
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural organization of the fibrinogen macromolecule related to the process of fibrin formation.
    Velican D
    Rev Roum Med Intern; 1972; 9(5):419-36. PubMed ID: 4576978
    [No Abstract]   [Full Text] [Related]  

  • 13. Two families of synthetic peptides that enhance fibrin turbidity and delay fibrinolysis by different mechanisms.
    Pandi L; Kollman JM; Lopez-Lira F; Burrows JM; Riley M; Doolittle RF
    Biochemistry; 2009 Aug; 48(30):7201-8. PubMed ID: 19588915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of plasminogen with polymerizing fibrin and its derivatives, monitored with a photoaffinity cross-linker and electron microscopy.
    Weisel JW; Nagaswami C; Korsholm B; Petersen LC; Suenson E
    J Mol Biol; 1994 Jan; 235(3):1117-35. PubMed ID: 8289311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
    Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE
    J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
    Soya K; Terasawa F; Okumura N
    Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
    Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
    Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural and functional properties of thrombospondin.
    Lawler J
    Blood; 1986 May; 67(5):1197-209. PubMed ID: 3516249
    [No Abstract]   [Full Text] [Related]  

  • 20. The interaction of platelets, endothelium and fibrin with reference to fibrinolysis.
    Warren BA; Khan S; Vales O
    Thromb Diath Haemorrh Suppl; 1973; 56():35-50. PubMed ID: 4281940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.